DB959: Additional Phase I data

Additional data from a double-blind, dose-escalation U.S. Phase I trial in 76 healthy volunteers showed that the

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE